Skip to main content

Testimonials
Version 1.0 Accessories
Invest
Join OAK Waitlist

NEWFOOTER: Contact and Hours

Phone:	800.692.4380
Fax (Rx):	800.657.7362
Email:	info@fisherwallace.com
Free Prescription
Initiate a Return

Sign up...

Learn more about our groundbreaking technology.

By submitting your email address you confirm you are over 21 and agree to the Fisher Wallace Privacy Policy.

Resources
Accessories

Privacy
We Do Not Sell Customers' Personal Information
Annual Report
Privacy Policy
Terms of Service

About
Reviews
FAQ
Treatment instructions

For Version 1.0 Customers
Accessories

Contact Us
Fisher Wallace Laboratories, Inc.
630 Flushing Avenue
Suite 104
Brooklyn, NY 11206

Phone: 800.692.4380
Fax (rx): 800.657.7362
Email: info@fisherwallace.com

Copyright © 2026

___________________________________

Equity crowdfunding investments in private placements, and start-up investments in particular, are speculative and involve a high degree of risk and those investors who cannot afford to lose their entire investment should not invest in start-ups. Companies seeking startup investment through equity crowdfunding tend to be in earlier stages of development and their business model, products and services may not yet be fully developed, operational or tested in the public marketplace. There is no guarantee that the stated valuation and other terms are accurate or in agreement with the market or industry valuations. Further, investors may receive illiquid and/or restricted stock that may be subject to holding period requirements and/or liquidity concerns. Fisher Wallace has filed a Form C with the Securities and Exchange Commission in connection with its offering, a copy of which may be obtained here: https://www.sec.gov/Archives/edgar/data/1787792/000178779226000011/fwlformca2.pdf

Forward looking statements were included here that the Company believes to be accurate given the current information. They involve known and unknown risks, uncertainties and other important factors which if changed may affect the outcome(s). Read Reg CF Offering Circular/Risks:https://www.sec.gov/Archives/edgar/data/1787792/000178779226000011/fwlformca2.pdf Investment is speculative, illiquid & high risk.